NCT00478166 Posterior Cingulate Function in Persons With Risk Factors for Alzheimer's Disease Status COMPLETED Phase N/A
NCT00476008 Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease Status COMPLETED Phase PHASE4
NCT00471211 Study Evaluating the Safety, Tolerability and Efficacy of PBT2 in Patients With Early Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT00469456 Effect of Memantine on Functional Communication in Patients With Alzheimer's Disease Status COMPLETED Phase PHASE4
NCT00468897 A Study To Demonstrate The Bioequivalence Of Rosiglitazone XR (BRL-049653) 8mgs XR Manufactured At Two Different Sites. Status COMPLETED Phase PHASE1
NCT00459550 A Clinical Study to Assess Single and Repeat Doses of a New Medication (GSK933776) in Patients With Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT00455000 A Phase I, Single IV Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT00454870 Safety and Efficacy of MEM 3454 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT00448318 Evaluating the Effects of Music Interventions on Hospitalised People With Dementia Status UNKNOWN Phase PHASE2/PHASE3
NCT00443417 A Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT00440050 DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease Status COMPLETED Phase PHASE3
NCT00439166 Effects of Doxycycline and Rifampicin on Biomarkers of Alzheimer's Disease in the Cerebrospinal Fluid Status COMPLETED Phase PHASE3
NCT00438568 SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days) Status COMPLETED Phase PHASE2
NCT00428389 Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease Status COMPLETED Phase PHASE3
NCT00428090 Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease Status COMPLETED Phase PHASE3
NCT00423085 Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease Status COMPLETED Phase PHASE3
NCT00420420 MK0249 for the Symptomatic Treatment of Alzheimer's Disease (MK0249-011) Status COMPLETED Phase PHASE2
NCT00416078 Online Caregiver Psychoeducation and Support for Alzheimer's Status COMPLETED Phase PHASE2/PHASE3